Follistatin-344 vs IGF-1 LR3
Both are categorized under Muscle growth in our directory—here is how they differ in name, use, and label context.
Both are categorized under Muscle growth in our directory—here is how they differ in name, use, and label context.
PubMed paper counts, ClinicalTrials.gov listings, and regulatory context—aggregated from public databases.
Muscle growth
A peptide that blocks myostatin signaling—discussed for muscle mass but with serious safety unknowns.
Follistatin inhibits myostatin, a protein that limits muscle growth. Gene-therapy and peptide approaches have shown dramatic muscle gains in animals. Human use is experimental; long-term safety is not established.…
Muscle growth
A modified insulin-like growth factor with a longer half-life—highly potent and tightly regulated.
IGF-1 LR3 binds IGF receptors to promote muscle cell hyperplasia. It is significantly more potent than endogenous IGF-1 and carries hypoglycemia risk. Banned in sport; not a casual recovery peptide.…
Both are categorized under Muscle growth in our directory—here is how they differ in name, use, and label context. Follistatin-344 is categorized as Muscle growth; IGF-1 LR3 as Muscle growth. Follistatin-344: A peptide that blocks myostatin signaling—discussed for muscle mass but with serious safety unknowns. IGF-1 LR3: A modified insulin-like growth factor with a longer half-life—highly potent and tightly regulated.
No. They are different molecules with distinct names on labels and in research databases. Always match the full INCI or drug name—not a nickname on the front of the package.
Neither page is medical or anti-doping advice. Research peptides discussed in fitness communities may be prohibited in tested sport or unavailable as OTC supplements. Verify WADA lists and talk to a clinician.